Evidence map›Paper›PMID 35984842›Full record

ArticlePLoS biology2022

Designing and implementing a research integrity promotion plan: Recommendations for research funders.

Serge P J M Horbach, Lex M Bouter, George Gaskell, Maura Hiney, Panagiotis Kavouras, Niels Mejlgaard, Nick Allum, Noémie Aubert Bonn, Anna-Kathrine Bendtsen, Costas A Charitidis and 16 more

Abstract read
In one paragraph

Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Serge P J M HorbachAarhus University, Aarhus, Denmark.
Lex M BouterVrije Universiteit Amsterdam, Amsterdam, the Netherlands.
George GaskellLondon School of Economics and Political Science, London, United Kingdom.
Maura HineyHealth Research Board, Dublin, Ireland.
Panagiotis KavourasNational Technical University of Athens, Athens, Greece.
Niels MejlgaardAarhus University, Aarhus, Denmark.
Nick AllumUniversity of Essex, Colchester, United Kingdom.
Noémie Aubert BonnDepartment of Ethics, Law and Humanities, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Anna-Kathrine BendtsenAarhus University, Aarhus, Denmark.
Costas A CharitidisNational Technical University of Athens, Athens, Greece.
Nik ClaesenEuropean Association of Research Managers and Administrators, Brussels, Belgium.
Kris DierickxKU Leuven, Leuven, Belgium.
Anna DomaradzkaRobert Zajonc Institute for Social Studies, University of Warsaw, Warsaw, Poland.
Andrea Reyes ElizondoCentre for Science an Technology Studies, Leiden University, Leiden, the Netherlands.
Nicole FögerAustrian Agency for Research Integrity, Vienna, Austria.
Wolfgang KaltenbrunnerCentre for Science an Technology Studies, Leiden University, Leiden, the Netherlands.
Teodora KonachAustrian Agency for Research Integrity, Vienna, Austria.
Krishma LabibDepartment of Ethics, Law and Humanities, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Ana MarušićUniversity of Split School of Medicine, Split, Croatia.
Daniel PizzolatoKU Leuven, Leuven, Belgium.
Tine RavnAarhus University, Aarhus, Denmark.
Rea RojeDepartment of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.
Mads P SørensenAarhus University, Aarhus, Denmark.
Borana TarajEuropean Association of Research Managers and Administrators, Brussels, Belgium.
Giuseppe A VeltriUniversity of Trento, Trento, Italy.
Joeri K TijdinkVrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0002-1826-2274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various stakeholders in science have put research integrity high on their agenda. Among them, research funders are prominently placed to foster research integrity by requiring that the organizations and individual researchers they support make an explicit commitment to research integrity. Moreover, funders need to adopt appropriate research integrity practices themselves. To facilitate this, we recommend that funders develop and implement a Research Integrity Promotion Plan (RIPP). This Consensus View offers a range of examples of how funders are already promoting research integrity, distills 6 core topics that funders should cover in a RIPP, and provides guidelines on how to develop and implement a RIPP. We believe that the 6 core topics we put forward will guide funders towards strengthening research integrity policy in their organization and guide the researchers and research organizations they fund.

Indexed as

Research DesignResearch PersonnelHumansPolicy

Identifiers

PMID35984842
PMCPMC9432753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.